CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Preferred Stock	Common Stock	Additional Paid-In Capital Cumulative Effect, Period of Adoption, Adjustment	Additional Paid-In Capital	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Cumulative Effect, Period of Adoption, Adjustment	Total
Balance at Dec. 31, 2021	$ 30	$ 60		$ 85,414		$ 343,459	$ 1,517		$ 430,480
Increase (decrease) in shareholders' equity
Net Loss Attributable to the Company						202			202
Vested Restricted Stock and Performance Shares				(845)					(845)
Exercise of Stock Options and Stock Issuance to Directors				149					149
Stock Issuance, Net of Equity Issuance Costs				2,789					2,789
Stock-Based Compensation Expense				619					619
Preferred Stock Dividends Declared for the Period						(1,195)			(1,195)
Common Stock Dividends Declared for the Period						(6,660)			(6,660)
Other Comprehensive Loss							8,012		8,012
Balance at Mar. 31, 2022	30	60	$ (7,034)	81,092	$ 4,022	339,828	9,529	$ (3,012)	430,539
Balance at Dec. 31, 2021	30	60		85,414		343,459	1,517		430,480
Balance at Dec. 31, 2022	30	229		172,471		316,279	15,761		504,770
Increase (decrease) in shareholders' equity
Net Loss Attributable to the Company						(5,993)			(5,993)
Stock Repurchase		(3)		(5,006)					(5,009)
Vested Restricted Stock and Performance Shares		1		(1,029)					(1,028)
Exercise of Stock Options and Stock Issuance to Directors				241					241
Stock Issuance, Net of Equity Issuance Costs				(71)					(71)
Stock-Based Compensation Expense				830					830
Preferred Stock Dividends Declared for the Period						(1,195)			(1,195)
Common Stock Dividends Declared for the Period						(9,025)			(9,025)
Other Comprehensive Loss							(4,891)		(4,891)
Balance at Mar. 31, 2023	$ 30	$ 227		$ 167,436		$ 300,066	$ 10,870		$ 478,629